Public Meeting Notice

Public Meeting Notice  Board of Registration in Pharmacy (via Webex) — May 7, 2026

Thursday, May 7, 2026 at 8:00 a.m.
Posted: March 27, 2026 3 p.m.

Overview

This meeting will be by Webex Conference Call.

  • Webinar link: Meeting Link
  • Meeting number: 2538 470 3456
  • Webinar Password: BOP123

Join by telephone

  • +1-617-315-0704 United States Toll (Boston)
  • +1-650-479-3208 United States Toll
  • Global call-in numbers | Toll-free calling restrictions 

If you need reasonable accommodations in order to participate in the meeting, contact the DPH ADA Coordinator Stacy Hart, Stacy.Hart@mass.gov or 857-274-1120 in advance of the meeting. While the Board will do its best to accommodate you, certain accommodation may require distinctive requests or the hiring of outside contractors and may not be available if requested immediately before the meeting.

Agenda

TimeItem #ItemStaff Member
8:00 CALL TO ORDER 

S. 

Dinno 

8:05 II APPROVAL OF AGENDA  
8:10 III 

APPROVAL OF BOARD MINUTES 

•Draft of March 26, 2026, Regular Session Minutes 

 
8:15 IV 

REPORTS 

  • Applications approved pursuant to Licensure Policy 13-01 
  • Monthly report from Probation 
  • Board Delegated Review pursuant to Licensure Policy 14-02 
  • URAMP Activity Report 
 
8:30    V 

FLEX 

  • New reporting forms 
  • Notice of opportunity for Board Approved Inspector: Real Solutions Group 
  • Report of April 29th Pharmacy Advisory Committee meeting 
  • Medical Debt Regulation: 140 CMR 2.00 

   

8:45 VI 

APPLICATIONS 

  • Blend Labs Rx LLC o Non-Resident Retail Pharmacy License NDSNE32293 oNon-Resident Complex Non-Sterile Compounding; NDSNE62217NS 
  • CSI Pharmacy  oRetail Pharmacy, DSNE10000467 (waiver) 
  • Alchemist Pharma o Non-Resident Sterile Compounding NDSNE97499SC 
  • Professional Pharmacy Resources o Non-Resident Complex Non-Sterile Compounding NDSNE62212NS 
  • Premium Health Care o Non-Resident Retail Pharmacy NDSNE32197 oNon-Resident Sterile Compounding NDSNE97564SC 
  • Wells Pharmacy Network o Non-Resident Retail - NDSNE31948  oNon-Resident Complex Compounding o Non-Resident Sterile Compounding 
  • Mass Vax o Request for a change of controlled substance schedules  DSDS10000012 
  • Springfield Pharmacy o Retail Pharmacy DSNE10000541 
 
9:30 VII 

HEARING ON DENIAL OF APPLICATION FOR A NON-RESIDENT RETAIL PHARMACY-

STERILE COMPOUNDING LICENSE 

•     Promise Pharmacy, NDS31881 Denial of application for non-resident retail pharmacy – sterile compounding license. (NDS31881SC) 

 
10:00 VIII 

INVESTIGATIVE CONFERENCE 

•Drug Crafters, NDS31755; PHA-2025-0158

 
10:30 IX FILE REVIEW  
  1  CASE-2025-3610  PHA-2025-0135  Walgreens #3112, DS2798  
 2  CASE-2025-3609  PHA-2025-0139  Walgreens #10318, DS89638  
 3  CASE-2025-3875  PHA-2025-0158  Drug Crafters, NDS31755  
 4  CASE-2026-0268  PHA-2026-0021  Prescription Center Pharmacy, DS89916  
 5  CASE-2026-0507  PHA-2026-0029  Lifespan of Massachusetts-Fall River, Inc. d/b/a Brown University Health Cancer Institute at Foxboro, St. Anne's Hospital, IS21079  
 6  CASE-2025-4244  PHA-2026-0015  Precision Medication INC. dba Precision Medicine, NDS31653  
 7  CASE-2026-0534  PHA-2026-0038  American Life Pharmacy, NDS31969  
 8  CASE-2025-4243  PHA-2026-0012  Revive Rx , NDS31277  
 9  CASE-2026-0608  PHA-2026-0042  Imprimis NJOF, LLC, NO00040  
10  CASE-2025-3670  PHA-2025-0143  Walgreens #17650, DS90229  
11  CASE-2025-3963  PHA-2025-0159  Walgreens #11120, DS89681  
12  CASE-2025-4058  PHA-2025-0166  Star Market Pharmacy #3577, DS3163  
13  CASE-2025-3504  PHA-2025-0130  CVS #1866, DS2956   
14  CASE-2025-3602  PHA-2025-0134  CVS #1249, DS2688  
15  CASE-2026-0009  PHA-2026-0007  CVS #5464, DS89826  
16  CASE-2026-0047  PHA-2026-0014  CVS #5464, DS89826  
  
11:30 

EXECUTIVE SESSION 

The Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition, or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual. Specifically, to evaluate the Good Moral Character as required for registration for a pending applicant and to conduct a hearing regarding a license denial.   

 
12:30  LUNCH BREAK  
1:00 XI ADJUDICATORY SESSION (M.G.L. c. 30A, § 18)  
1:15 XII M.G.L. c. 112, § 65C SESSION  
4:00  ADJOURNMENT  

Help Us Improve Mass.gov  with your feedback

Please do not include personal or contact information.
Feedback